Franklin Resources
BPMC

Franklin Resources’s Blueprint Medicines BPMC Stock Holding History

Franklin Resources’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-173,510
Closed -$22.2M – 3149
2025
Q2 		$22.2M Buy
173,510
+37,399
+27% +$3.88M 0.01% 897
2025
Q1 		$12M Buy
136,111
+99,525
+272% +$9.71M ﹤0.01% 1051
2024
Q4 		$3.19M Sell
36,586
-175
-0.5% -$16K ﹤0.01% 1545
2024
Q3 		$3.26M Buy
36,761
+265
+0.7% +$26.3K ﹤0.01% 1540
2024
Q2 		$3.93M Buy
36,496
+7,205
+25% +$721K ﹤0.01% 1413
2024
Q1 		$2.78M Buy
29,291
+23,951
+449% +$2.05M ﹤0.01% 1591
2023
Q4 		$493K Buy
+5,340
New +$346K ﹤0.01% 1952
2022
Q2 		– Sell
-413,665
Closed -$26.4M – 2375
2022
Q1 		$26.4M Sell
413,665
-6,981
-2% -$501K 0.01% 778
2021
Q4 		$45.1M Sell
420,646
-71,641
-15% -$7.49M 0.02% 668
2021
Q3 		$50.6M Sell
492,287
-18,734
-4% -$1.74M 0.02% 656
2021
Q2 		$44.9M Buy
511,021
+488
+0.1% +$44.7K 0.02% 682
2021
Q1 		$49.6M Sell
510,533
-183
-0% -$18.3K 0.02% 622
2020
Q4 		$57.3M Sell
510,716
-375
-0.1% -$39.5K 0.02% 553
2020
Q3 		$47.4M Buy
511,091
+114,067
+29% +$8.78M 0.02% 565
2020
Q2 		$31.1M Buy
397,024
+296,941
+297% +$20.1M 0.02% 638
2020
Q1 		$5.85M Buy
+100,083
New +$6.44M ﹤0.01% 905
2017
Q2 		– Sell
-200,000
Closed -$8M – 1506
2017
Q1 		$8M Hold
200,000
– – ﹤0.01% 1017
2016
Q4 		$5.61M Buy
+200,000
New +$6.03M ﹤0.01% 1064

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Franklin Resources's BPMC Position: Q3 2025 in Review

Franklin Resources sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 173,510 shares — an estimated $22.2M sold.

Franklin Resources first reported a position in BPMC in Q4 2016 and held it in 18 quarters. The position peaked at $57.3M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Franklin Resources reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Franklin Resources sold 173,510 Blueprint Medicines shares in Q3 2025, an estimated $22.2M.
  • Franklin Resources first reported a position in Blueprint Medicines in Q4 2016 and held it in 18 quarters.
  • Franklin Resources's Blueprint Medicines position peaked at $57.3M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Franklin Resources's 13F filing for Q3 2025, filed 13 Nov 2025.